The administration of Ad-IL-17AR:Fc consistently reduced the systemic TNF-α and IL-6 production on day 60 and 90 post-infection in viral myocarditis, especially on day 90 (Fig. 1A and B). This evidence concerns the gene TNF and viral myocarditis.